Saji M, Ikuyama S, Akamizu T, Kohn L D
Section on Cell Regulation, National Institute of Diabetes and Kidney and Digestive Diseases, National Institutes of Health, Bethesda, MD 20892.
Biochem Biophys Res Commun. 1991 Apr 15;176(1):94-101. doi: 10.1016/0006-291x(91)90894-d.
Thyrotropin (TSH) receptor mRNA levels in rat FRTL-5 thyroid cells are decreased by treatment with the calcium ionophores, A23187 or ionomycin, as well as with TSH, cholera toxin, forskolin, and 8-bromo-cAMP. Down regulation is, in each case, associated with a decrease in [125I]TSH binding and a decreased ability of TSH to increase cAMP levels. The ionophore does not alter cAMP levels and ethylene glycol-bis-(beta-aminoethyl ether) N, N'-tetraacetic acid (EGTA) in the medium prevents down regulation of TSH receptor mRNA levels by the ionophore, but not by TSH; the EGTA action is reversed by the simultaneous addition of Ca++. Whereas down regulation by TSH and its cAMP signal requires the presence of insulin and/or serum in the medium; down regulation by a calcium ionophore is still evident in their absence. Down regulation of TSH receptor mRNA levels and receptor desensitization by TSH/cAMP or an ionophore is lost in cells transfected with a full length TSH receptor cDNA devoid of regulatory elements, but able to reconstitute TSH receptor signal generation.
用钙离子载体A23187或离子霉素、促甲状腺激素(TSH)、霍乱毒素、福斯可林和8-溴环磷酸腺苷(8-bromo-cAMP)处理大鼠FRTL-5甲状腺细胞后,促甲状腺激素(TSH)受体mRNA水平会降低。在每种情况下,下调都与[125I]TSH结合减少以及TSH升高环磷酸腺苷(cAMP)水平的能力降低有关。离子载体不会改变cAMP水平,培养基中的乙二醇双(β-氨基乙醚)N,N'-四乙酸(EGTA)可防止离子载体下调TSH受体mRNA水平,但不能防止TSH下调;同时添加Ca++可逆转EGTA的作用。虽然TSH及其cAMP信号引起的下调需要培养基中存在胰岛素和/或血清;但在没有它们的情况下,钙离子载体引起的下调仍然很明显。在用缺乏调节元件但能够重建TSH受体信号产生的全长TSH受体cDNA转染的细胞中,TSH/cAMP或离子载体引起的TSH受体mRNA水平下调和受体脱敏消失。